Experts Worry AstraZeneca Sidelining Will Compound Vaccine Hesitancy

The video discusses the AstraZeneca vaccine rollout, highlighting concerns about blood clotting and the suspension of its use in Europe. Despite these issues, the European Medicines Agency and WHO maintain that the vaccine's benefits outweigh the risks. The vaccine is being debated globally, with some countries like Australia considering suspension. AstraZeneca faces regulatory challenges, including seeking FDA approval, amid public hesitancy.

What is the main reason for the suspension of the AstraZeneca vaccine rollout in Europe?

• Concerns about blood clotting

• Lack of vaccine supply

• High cost of the vaccine

• Ineffectiveness against COVID-19

Which organization continues to support the AstraZeneca vaccine despite the concerns?

• EMA

• CDC

• WHO

• FDA

In which regions has the AstraZeneca vaccine been rolled out?

• Only in Europe

• Only in Asia

• Europe, Asia, and Australia

• Only in Australia

What is the main concern for AstraZeneca in seeking FDA approval?

• Lack of demand

• High production costs

• Competition from other vaccines

• Past trial issues

How might the suspension of the AstraZeneca vaccine affect public perception?

• Increase vaccine acceptance

• Decrease vaccine hesitancy

• Have no effect on public perception

• Increase vaccine hesitancy